Brian Acker, CA
Member since: Oct '00
Chief Executive Officer, President and Chief Inves at
Acker Finley Inc.

Latest Top Picks

(A Top Pick Feb 08/19, Down 4%) This one has ever been cheaper. This is a value/contrarian play. It is one of the best managed companies in the world.
(A Top Pick Feb 08/19, Down 7%) All the drugs have been moving spectacularly. There is a lot of value. His model price is 48.79 or a 28% upside. If we have a fall, these stocks will do very well.
(A Top Pick Feb 08/19, Up 17%) His model price is $95.50, or a 70% upside. It is cheap by his metrics.
It is the cheapest it has been since 1995. 5% yield; one of the best companies in the world and at a cheap price. (Analysts’ price target is $78.16)
The drug space all have huge upsides. He has owned it for quite some time. Model rice is $185.42 which is a 33% upside. There is a lot of value here. (Analysts’ price target is $150.39)